---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-135285"
form_type: "8-K"
ticker: "VCNX"
cik: "0001205922"
company_name: "VACCINEX, INC."
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T04:58:14.990095+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Vaccinex shareholders elect directors, approve say-on-pay and incentive plan amendment

## Summary
- Elected Jacob Frieberg, Albert Friedberg, and Maurice Zauderer as directors with >425k votes each.
- Advisory say-on-pay passed with 521,607 votes for vs 27,555 against.
- Shareholders chose annual frequency for future say-on-pay votes (539,907 for 1 year).
- First amendment to 2018 Omnibus Incentive Plan approved 403,835 for, 146,143 against.
- Ratified Deloitte & Touche as auditor for FY2024 with 674,404 votes for.

## SEC filing metadata
- accession: 0001193125-24-135285
- form_type: 8-K
- ticker: VCNX
- cik: 0001205922
- company_name: VACCINEX, INC.
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1205922/000119312524135285/0001193125-24-135285-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1205922/000119312524135285/d800537d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-135285
- JSON: https://secwatch.observer/filing/0001193125-24-135285.json
- Plain text: https://secwatch.observer/filing/0001193125-24-135285.txt

## Key facts
- Shareholder Votes
  VACCINEX, INC. shareholders approved Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2024 at the 2024-05-09 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2024-05-09
  source text: Proposal 5. The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. Votes For Votes Against Votes Abstained 674,404 8,972 417
  evidence_url: https://www.sec.gov/Archives/edgar/data/1205922/000119312524135285/0001193125-24-135285-index.htm
- Shareholder Votes
  VACCINEX, INC. shareholders approved Approval of First Amendment to the Vaccinex, Inc. 2018 Omnibus Incentive Plan at the 2024-05-09 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2024-05-09
  source text: Proposal 4. The Company’s stockholders approved the First Amendment to the Vaccinex, Inc. 2018 Omnibus Incentive Plan. Votes For Votes Against Votes Abstained Broker Non-Votes 403,835 146,143 308 133,507
  evidence_url: https://www.sec.gov/Archives/edgar/data/1205922/000119312524135285/0001193125-24-135285-index.htm
- Shareholder Votes
  VACCINEX, INC. shareholders approved Election of three directors for three-year terms expiring in 2027 at the 2024-05-09 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2024-05-09
  source text: Proposal 1. The Company’s stockholders elected the following nominees as directors, each to serve for a three-year term expiring in 2027. Director Nominee Votes For Authority Withheld Broker Non-Votes Jacob Frieberg 425,443 124,843 133,507 Albert Friedberg 425,131 124,155 133,507 Maurice Zauderer 425,477 124,809 133,507
  evidence_url: https://www.sec.gov/Archives/edgar/data/1205922/000119312524135285/0001193125-24-135285-index.htm
- Shareholder Votes
  VACCINEX, INC. shareholders approved Non-binding advisory vote on compensation of named executive officers at the 2024-05-09 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2024-05-09
  source text: Proposal 2. The Company’s stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers. Votes For Votes Against Votes Abstained Broker Non-Votes 521,607 27,555 1,124 133,507
  evidence_url: https://www.sec.gov/Archives/edgar/data/1205922/000119312524135285/0001193125-24-135285-index.htm
- Shareholder Votes
  VACCINEX, INC. shareholders approved Advisory vote on frequency of future say-on-pay votes (every year, 2 years, or 3 years) at the 2024-05-09 meeting.
  - Proposal: say on pay frequency
  - Outcome: passed
  - Meeting: 2024-05-09
  source text: Proposal 3. The Company’s stockholders determined, on a non-binding advisory basis, that future advisory votes on the compensation of the Company’s named executive officers shall be held every year. Votes For 1 Year Votes For 2 Years Votes For 3 Years Votes Abstained 539,907 1,950 7,045 1,384
  evidence_url: https://www.sec.gov/Archives/edgar/data/1205922/000119312524135285/0001193125-24-135285-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.